Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cts (CTS) Research & Development (2016 - 2025)

Cts (CTS) has disclosed Research & Development for 16 consecutive years, with $6.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 37.17% year-over-year to $6.9 million, compared with a TTM value of $23.9 million through Sep 2025, up 4.0%, and an annual FY2024 reading of $23.4 million, down 6.14% over the prior year.
  • Research & Development was $6.9 million for Q3 2025 at Cts, up from $6.3 million in the prior quarter.
  • Across five years, Research & Development topped out at $6.9 million in Q3 2025 and bottomed at $5.0 million in Q3 2024.
  • Average Research & Development over 5 years is $6.1 million, with a median of $6.2 million recorded in 2022.
  • The sharpest move saw Research & Development fell 23.23% in 2021, then skyrocketed 37.17% in 2025.
  • Year by year, Research & Development stood at $5.7 million in 2021, then dropped by 4.94% to $5.4 million in 2022, then decreased by 2.13% to $5.3 million in 2023, then rose by 7.18% to $5.7 million in 2024, then increased by 21.71% to $6.9 million in 2025.
  • Business Quant data shows Research & Development for CTS at $6.9 million in Q3 2025, $6.3 million in Q2 2025, and $5.7 million in Q4 2024.